Outcomes and Complications of Hemodialysis in Patients with Renal Cancer Following Bilateral Nephrectomy

Overview

Journal Open Med (Wars)

Specialty General Medicine

Date 2024 Sep 2

PMID 39221033

Authors

Bing Shen

Feng Luo

Nan Yuan

Jiaming Yin

Yalin Chai

Lijie Sun

Lin Zhang

Congjuan Luo

Affiliations

Soon will be listed here.

Abstract

Objectives: The management of patients undergoing bilateral nephrectomy for renal cancer presents significant challenges, particularly in addressing hypotension, anemia, and tumor recurrence during hemodialysis.

Case Presentation: A patient diagnosed with renal clear cell carcinoma in 2009 was followed until his demise in June 2022, with detailed documentation of symptoms, signs, laboratory results, diagnosis, and treatment. In the presented case, post-nephrectomy, the patient experienced frequent hypotension and anemia during dialysis, improving with erythropoietin-stimulating agents and subsequently with rosuvastatin. Later, multiple metastases were detected, correlating with normalized blood pressure and hemoglobin.

Literature Review: A literature search up to September 2023 was also conducted, gathering data on hypotension, anemia, and tumor recurrence post-nephrectomy. Literature analysis of six cases revealed a 100% tumor recurrence rate in elderly patients (>50 years).

Conclusion: Treatment of anemia in bilateral nephrectomy patients warrants consideration of medication-induced tumor recurrence, highlighting early kidney transplantation to avoid adverse reactions like hypotension.

References

Morinaga R, Kawahara T, Miyoshi Y, Yao M, Uemura H . Longer Control of Nivolumab in Metastatic Renal Cell Carcinoma Patients with End-Stage Kidney Disease on Dialysis. Case Rep Oncol. 2019; 12(2):608-612. PMC: 6738248. DOI: 10.1159/000501768. View

Brownstein C, Daguenet E, Guyotat D, Millet G . Chronic fatigue in myelodysplastic syndromes: Looking beyond anemia. Crit Rev Oncol Hematol. 2020; 154:103067. DOI: 10.1016/j.critrevonc.2020.103067. View

Kobari Y, Yoshida K, Iizuka J, Kondo T, Ishida H, Tanabe K . Three Cases of Nivolumab Plus Ipilimumab Therapy in Haemodialysis Patients With Metastatic Renal Cell Carcinoma. In Vivo. 2021; 35(6):3585-3589. PMC: 8627745. DOI: 10.21873/invivo.12663. View

Fuchs F, Whelton P . High Blood Pressure and Cardiovascular Disease. Hypertension. 2019; 75(2):285-292. PMC: 10243231. DOI: 10.1161/HYPERTENSIONAHA.119.14240. View

Desoye G, Carter A . Fetoplacental oxygen homeostasis in pregnancies with maternal diabetes mellitus and obesity. Nat Rev Endocrinol. 2022; 18(10):593-607. DOI: 10.1038/s41574-022-00717-z. View

Chan L, Chaudhary K, Saha A, Chauhan K, Vaid A, Zhao S . AKI in Hospitalized Patients with COVID-19. J Am Soc Nephrol. 2020; 32(1):151-160. PMC: 7894657. DOI: 10.1681/ASN.2020050615. View

Henke M, Laszig R, Rube C, Schafer U, Haase K, Schilcher B . Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial. Lancet. 2003; 362(9392):1255-60. DOI: 10.1016/S0140-6736(03)14567-9. View

Chewcharat A, Chewcharat P, Liu W, Cellini J, Phipps E, Melendez Young J . The effect of levocarnitine supplementation on dialysis-related hypotension: A systematic review, meta-analysis, and trial sequential analysis. PLoS One. 2022; 17(7):e0271307. PMC: 9282471. DOI: 10.1371/journal.pone.0271307. View

Stefansson B, Brunelli S, Cabrera C, Rosenbaum D, Anum E, Ramakrishnan K . Intradialytic hypotension and risk of cardiovascular disease. Clin J Am Soc Nephrol. 2014; 9(12):2124-32. PMC: 4255399. DOI: 10.2215/CJN.02680314. View

10.

Qiyan Zheng , Yang H, Sun L, Wei R, Fu X, Wang Y . Efficacy and safety of HIF prolyl-hydroxylase inhibitor vs epoetin and darbepoetin for anemia in chronic kidney disease patients not undergoing dialysis: A network meta-analysis. Pharmacol Res. 2020; 159:105020. DOI: 10.1016/j.phrs.2020.105020. View

11.

Wish J, Eckardt K, Kovesdy C, Fishbane S, Spinowitz B, Berns J . Hypoxia-Inducible Factor Stabilization as an Emerging Therapy for CKD-Related Anemia: Report From a Scientific Workshop Sponsored by the National Kidney Foundation. Am J Kidney Dis. 2021; 78(5):709-718. DOI: 10.1053/j.ajkd.2021.06.019. View

12.

Tang R, Wu Z, Rong Z, Xu J, Wang W, Zhang B . Ferroptosis-related lncRNA pairs to predict the clinical outcome and molecular characteristics of pancreatic ductal adenocarcinoma. Brief Bioinform. 2021; 23(1). DOI: 10.1093/bib/bbab388. View

13.

Bayik D, Lathia J . Cancer stem cell-immune cell crosstalk in tumour progression. Nat Rev Cancer. 2021; 21(8):526-536. PMC: 8740903. DOI: 10.1038/s41568-021-00366-w. View

14.

Gaete D, Rodriguez D, Watts D, Sormendi S, Chavakis T, Wielockx B . HIF-Prolyl Hydroxylase Domain Proteins (PHDs) in Cancer-Potential Targets for Anti-Tumor Therapy?. Cancers (Basel). 2021; 13(5). PMC: 7956578. DOI: 10.3390/cancers13050988. View

15.

Hsu C, Tain Y . Targeting the Renin-Angiotensin-Aldosterone System to Prevent Hypertension and Kidney Disease of Developmental Origins. Int J Mol Sci. 2021; 22(5). PMC: 7956566. DOI: 10.3390/ijms22052298. View

16.

Ohta Y, Fukuhara M, Fujisawa R, Kanesaki M, Tsuruta H, Nakamura H . Influence of blood pressure variations during hemodialysis on the prognosis of dialysis patients. Clin Exp Hypertens. 2023; 45(1):2236336. DOI: 10.1080/10641963.2023.2236336. View

17.

Bruchfeld A . The COVID-19 pandemic: consequences for nephrology. Nat Rev Nephrol. 2020; 17(2):81-82. PMC: 7703720. DOI: 10.1038/s41581-020-00381-4. View

18.

Chrabanska M, Jakub R, Bogna D . Bilateral and Multifocal Acquired Cystic Disease-Associated Renal Cell Carcinomas in Patient With End-Stage Renal Disease Caused by Systemic Lupus Erythematosus. Int J Surg Pathol. 2020; 29(2):198-204. DOI: 10.1177/1066896920928586. View

19.

Mc Causland F, Tumlin J, Roy-Chaudhury P, Koplan B, Costea A, Kher V . Intradialytic Hypotension and Cardiac Arrhythmias in Patients Undergoing Maintenance Hemodialysis: Results from the Monitoring in Dialysis Study. Clin J Am Soc Nephrol. 2020; 15(6):805-812. PMC: 7274298. DOI: 10.2215/CJN.06810619. View

20.

Bradley A, Maskell G, Mannava A, Pollard A, Welsh T . Routes to diagnosis and missed opportunities in the detection of renal cancer. Clin Radiol. 2020; 76(2):129-134. DOI: 10.1016/j.crad.2020.11.005. View